Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (12) , 1638-1644
- https://doi.org/10.1016/s0002-9149(99)00170-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cardiac Sympathetic Nerve Function in Congestive Heart FailureCirculation, 1996
- Adverse consequences of high sympathetic nervous activity in the failing human heartJournal of the American College of Cardiology, 1995
- Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failureJournal of the American College of Cardiology, 1994
- Adrenergic effects on the biology of the adult mammalian cardiocyte.Circulation, 1992
- A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline ReceptorsJournal of Cardiovascular Pharmacology, 1992
- Moxonidine: A Second Generation of Centrally Acting DrugsJournal of Cardiovascular Pharmacology, 1992
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.Circulation, 1986
- Effects of catecholamines on lactic acid output during progressive working contractionsJournal of Applied Physiology, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984